Effects	effects	O	O	O	O
of	of	O	O	O	O
acetylsalicylic	acetylsalicylic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
dipyridamole	dipyridamole	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
hydrocortisone	hydrocortisone	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
epinephrine-induced	epinephrine-induced	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
in	in	O	O	O	O
dogs	dogs	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
reproducible	reproducible	O	O	O	O
model	model	O	O	O	O
for	for	O	O	O	O
producing	producing	O	O	O	O
diffuse	diffuse	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
(	(	O	O	O	O
epinephrine	epinephrine	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
)	)	O	O	O	O
has	has	O	O	O	O
been	been	O	O	O	O
developed	developed	O	O	O	O
to	to	O	O	O	O
study	study	O	O	O	O
the	the	O	O	O	O
cardioprotective	cardioprotective	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
agents	agents	O	O	O	O
or	or	O	O	O	O
maneuvers	maneuvers	O	O	O	O
which	which	O	O	O	O
might	might	O	O	O	O
alter	alter	O	O	O	O
the	the	O	O	O	O
evolution	evolution	O	O	O	O
of	of	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
myocardial	myocardial	O	DISEASE	OTHERS	I
infarction	infarction	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Infusions	infusions	O	O	O	O
of	of	O	O	O	O
epinephrine	epinephrine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
4	4	O	O	O	O
mug	mug	O	O	O	O
per	per	O	O	O	O
kilogram	kilogram	O	O	O	O
per	per	O	O	O	O
minute	minute	O	O	O	O
for	for	O	O	O	O
6	6	O	O	O	O
hours	hours	O	O	O	O
)	)	O	O	O	O
increased	increased	O	O	O	O
radiocalcium	radiocalcium	O	O	OTHERS	I
uptakes	uptakes	O	O	O	O
into	into	O	O	O	O
intact	intact	O	O	O	O
myocardium	myocardium	O	O	O	O
and	and	O	O	O	O
each	each	O	O	O	O
of	of	O	O	O	O
its	its	O	O	O	O
subcellular	subcellular	O	O	O	O
components	components	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
mitochondrial	mitochondrial	O	O	O	O
fraction	fraction	O	O	O	O
showing	showing	O	O	O	O
the	the	O	O	O	O
most	most	O	O	O	O
consistent	consistent	O	O	O	O
changes	changes	O	O	O	O
when	when	O	O	O	O
compared	compared	O	O	O	O
to	to	O	O	O	O
saline-infused	saline-infused	O	O	O	O
control	control	O	O	O	O
animals	animals	O	O	O	O
(	(	O	O	O	O
4,957	4,957	O	O	O	O
vs.	vs.	O	O	O	O
827	827	O	O	O	O
counts	counts	O	O	O	O
per	per	O	O	O	O
minute	minute	O	O	O	O
per	per	O	O	O	O
gram	gram	O	O	O	O
of	of	O	O	O	O
dried	dried	O	O	O	O
tissue	tissue	O	O	O	O
or	or	O	O	O	O
fraction	fraction	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Myocardial	myocardial	O	O	O	O
concentrations	concentrations	O	O	O	O
of	of	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
also	also	O	O	O	O
increased	increased	O	O	O	O
significantly	significantly	O	O	O	O
(	(	O	O	O	O
12.0	12.0	O	O	O	O
vs.	vs.	O	O	O	O
5.0	5.0	O	O	O	O
mg.per	mg.per	O	O	O	O
100	100	O	O	O	O
Gm	gm	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O
of	of	O	O	O	O
fat-free	fat-free	O	O	O	O
dry	dry	O	O	O	O
weight	weight	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Infusions	infusions	O	O	O	O
of	of	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
chloride	chloride	CHEMICALS	O	OTHERS	I
sufficient	sufficient	O	O	O	O
to	to	O	O	O	O
raise	raise	O	O	O	O
serum	serum	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
concentrations	concentrations	O	O	O	O
2	2	O	O	O	O
mEq	meq	O	O	O	O
.	.	O	O	O	O

per	per	O	O	O	O
liter	liter	O	O	O	O
failed	failed	O	O	O	O
to	to	O	O	O	O
increase	increase	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
influx	influx	O	O	O	O
into	into	O	O	O	O
the	the	O	O	O	O
myocardial	myocardial	O	O	O	O
cell	cell	O	O	O	O
.	.	O	O	O	O

Mitochondrial	mitochondrial	O	O	O	O
radiocalcium	radiocalcium	O	O	OTHERS	I
uptakes	uptakes	O	O	O	O
were	were	O	O	O	O
significantly	significantly	O	O	O	O
decreased	decreased	O	O	O	O
in	in	O	O	O	O
animals	animals	O	O	O	O
pretreated	pretreated	O	O	O	O
with	with	O	O	O	O
acetylsalicylic	acetylsalicylic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
dipyridamole	dipyridamole	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
when	when	O	O	O	O
hydrocortisone	hydrocortisone	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
added	added	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
epinephrine	epinephrine	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
(	(	O	O	O	O
2,682,2,803	2,682,2,803	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
3,424	3,424	O	O	O	O
counts	counts	O	O	O	O
per	per	O	O	O	O
minute	minute	O	O	O	O
per	per	O	O	O	O
gram	gram	O	O	O	O
of	of	O	O	O	O
dried	dried	O	O	O	O
fraction	fraction	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Myocardial	myocardial	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
concentrations	concentrations	O	O	O	O
also	also	O	O	O	O
were	were	O	O	O	O
decreased	decreased	O	O	O	O
(	(	O	O	O	O
11.2	11.2	O	O	O	O
,	,	O	O	O	O
8.3	8.3	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
8.9	8.9	O	O	O	O
mg	mg	O	O	OTHERS	I
.	.	O	O	O	O
per	per	O	O	O	O
100	100	O	O	O	O
Gm	gm	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O
of	of	O	O	O	O
fat-free	fat-free	O	O	O	O
dry	dry	O	O	O	O
weight	weight	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
)	)	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
three	three	O	O	O	O
treatment	treatment	O	O	O	O
groups	groups	O	O	O	O
,	,	O	O	O	O
being	being	O	O	O	O
significantly	significantly	O	O	O	O
decreased	decreased	O	O	O	O
only	only	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
last	last	O	O	O	O
two	two	O	O	O	O
.	.	O	O	O	O

Evidence	evidence	O	O	O	O
of	of	O	O	O	O
microscopic	microscopic	O	O	O	O
damage	damage	O	O	O	O
was	was	O	O	O	O
graded	graded	O	O	O	O
as	as	O	O	O	O
less	less	O	O	O	O
severe	severe	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
three	three	O	O	O	O
treatment	treatment	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

Acetylsalicylic	acetylsalicylic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
dipyridamole	dipyridamole	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
hydrocortisone	hydrocortisone	CHEMICALS	O	OTHERS	I
all	all	O	O	O	O
appear	appear	O	O	O	O
to	to	O	O	O	O
have	have	O	O	O	O
cardioprotective	cardioprotective	O	O	O	O
effects	effects	O	O	O	O
when	when	O	O	O	O
tested	tested	O	O	O	O
in	in	O	O	O	O
this	this	O	O	O	O
model	model	O	O	O	O
.	.	O	O	O	O

